Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

  • STATUS
    Recruiting
  • participants needed
    100
  • sponsor
    Sixth Affiliated Hospital, Sun Yat-sen University
Updated on 19 February 2024
cancer
metastasis
adenocarcinoma
MRI
chemoradiotherapy
fluorouracil
adjuvant therapy
adjuvant chemotherapy
rectal cancer
adenocarcinoma of rectum
adjuvant

Summary

In this study, investigators utilize a radiomics prediction model to predict the tumor response to neoadjuvant chemoradiotherapy (nCRT) before the nCRT is administered for patients with locally advanced rectal cancer (LARC). Previously, the radiomics prediction model has been constructed based on the radiomics features extracted from pretreatment Magnetic Resonance Imaging (MRI) in the training set, and optimized in the external validation set. The predictive power of this radiomics prediction model to discriminate the pathologic complete response (pCR) patients from non-pCR individuals, will be further verified in this prospective, multicenter clinical study.

Description

This is a multicenter, prospective, observational clinical study for validation of a radiomics-based artificial intelligence (AI) prediction model. Patients who have been pathologically diagnosed as rectal adenocarcinoma and defined as clinical II-III staging without distant metastasis will be enrolled from the Sixth Affiliated Hospital of Sun Yat-sen University, the Third Affiliated Hospital of Kunming Medical College and Sir Run Run Shaw Hospital Affiliated by Zhejiang University School of Medicine. All participants should follow a standard treatment protocol, including concurrent neoadjuvant chemoradiotherapy (nCRT), total mesorectum excision (TME) surgery and adjuvant chemotherapy. Enhanced Magnetic Resonance Imaging (MRI) examination should be completed before the administration of nCRT treatment. The tumor volumes at high solution T2-weighted, contrast-enhanced T1-weighted and diffusion weighted images will be manually delineated, respectively. The outlined MRI images will be captured by the radiomics prediction model to generate a predicted response ("predicted pCR" vs. "predicted non-pCR") of each patient, whereas the true response ("confirmed pCR" vs. "confirmed non-pCR") is derived from pathologic reports after TME surgery serving as the gold standard for evaluation. The prediction accuracy, specificity, sensitivity and Area Under Curve (AUC) of Receiver Operating Characteristic (ROC) curves will be calculated. This study is aimed to provide a reliable and accurate AI system to predict the pathologic tumor response to nCRT before its administration, which might facilitate the identification of pCR candidates for further precision therapy among patients with locally advanced rectal cancer.

Details
Condition Colorectal Cancer, Colorectal Cancer, Rectal Cancer, Rectal Cancer
Age 18-75 years
Clinical Study IdentifierNCT04273477
SponsorSixth Affiliated Hospital, Sun Yat-sen University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

pathologically diagnosed as rectal adenocarcinoma
defined as clinical II-III staging (T3, and/or positive nodal status) without distant metastasis by enhanced Magnetic Resonance Imaging (MRI)
intending to receive or undergoing neoadjuvant concurrent chemoradiotherapy (5-fluorouracil based chemotherapy, given orally or intravenously; Intensity-Modulated Radiotherapy or Volume-Modulated Radiotherapy delivered at 50 gray (Gy) in gross tumor volume (GTV) and 45 Gy in clinical target volume (CTV) by 25 fractions)
intending to receive total mesorectum excision (TME) surgery after neoadjuvant therapy (not completed at the enrollment), and adjuvant chemotherapy
MRI (high-solution T2-weighted imaging, contrast-enhanced T1-weighted imaging, and diffusion-weighted imaging are required) examination is completed before the neoadjuvant chemoradiotherapy

Exclusion Criteria

with history of other cancer
insufficient imaging quality of MRI to delineate tumor volume or obtain measurements (e.g., lack of sequence, motion artifacts)
incomplete neoadjuvant chemoradiotherapy
no surgery after neoadjuvant chemoradiotherapy resulting in lack of pathologic assessment of tumor response
tumor recurrence or distant metastasis during neoadjuvant chemoradiotherapy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.